m6A-centered Disease Response Information
General Information of the Disease (ID: M6ADIS0165)
| Name |
Skin tumour
|
||||
|---|---|---|---|---|---|
| ICD |
ICD-11: 2F92
|
||||
Full List of Target Gene(s) of This m6A-centered Disease Response
DNA damage-binding protein 2 (DDB2)
| In total 1 item(s) under this target gene | ||||
| Experiment 1 Reporting the m6A-centered Disease Response by This Target Gene | [1] | |||
| Response Summary | METTL14 knockdown decreases GGR and DNA damage-binding protein 2 (DDB2) abundance. Conversely, overexpression of wild-type METTL14 but not its enzymatically inactive mutant increases GGR and DDB2 abundance. METTL14 is a target for selective autophagy and acts as a critical epitranscriptomic mechanism to regulate GGR and suppress UVB-induced skin tumorigenesis. | |||
| Responsed Disease | Skin tumour [ICD-11: 2F92] | |||
| Target Regulator | Methyltransferase-like 14 (METTL14) | WRITER | ||
| Target Regulation | Up regulation | |||
| Pathway Response | Nucleotide excision repair | hsa03420 | ||
| Cell Process | Genome repair | |||
| Cell autophagy | ||||
| In-vitro Model | NHEK (Normal human epithelial keratinocytes) | |||
| MEF (Mouse embryonic fibroblasts) | ||||
| HaCaT | Normal | Homo sapiens | CVCL_0038 | |
| A-431 | Skin squamous cell carcinoma | Homo sapiens | CVCL_0037 | |